According to the latest market report published by Persistence Market Research (PMR) titled ‘Global Feminine Hygiene Product Market: Global Industry Analysis and Forecast, 2016-2024, the global feminine hygiene market is expected to expand at CAGR of 7.2% over the forecast period (2016-2024) in terms of value.
The report has categorically been divided into three sections namely by product type, distribution channel, and region. On the basis of product type, the global feminine hygiene market has been segmented into sanitary napkins/pads, tampons, panty liners, menstrual cup, and feminine hygiene wash. On the basis of a distribution channel, the global feminine hygiene market has been segmented into a supermarket, convenience stores, department stores, retail pharmacies, and online purchase. By product type, sanitary napkin/pad segment is expected to expand at highest CAGR of 8.4% over the forecast period, in terms of value, attributed to increasing awareness about the benefits of sanitary napkins/pads. This segment is expected to be valued at US$ 16,896.8 Mn by 2024 end.
View Sample Report @ http://www.persistencemarketresearch.com/samples/3226
By product type, tampons segment is expected to be the second most dominant segment during the forecast period.
By distribution channel, supermarket segment is expected to dominate the global feminine hygiene market over the forecast period, followed by department stores distribution channel segment.
To Know About Latest Report Click Here: http://www.persistencemarketresearch.com/market-research/feminine-hygiene-product-market.asp
According to a new market report published by Persistence Market Research “Global Market Study on E-Clinical Solution Software: Asia to Witness Highest Growth by 2020”, the global e-clinical solution software market was valued at US$ 3,005 Mn in 2014 and is expected to expand at a CAGR of 13.8% from 2014 to 2020, to reach US$ 6,515.3 Mn by 2020.
The global e-clinical solution software market is witnessing significant growth due to increasing clinical trials and R&D investments in pharmaceuticals and life science sectors. Increasing prevalence of diseases across the world is leading to rise in number of clinical trials. Various lifestyle-associated diseases and genetic disorders in the Middle East and North Africa have also led to increase in clinical trials in the respective regions. In addition, the pharmaceutical industry is facing immense pressure to reduce the time consumed to conduct clinical trials and increase effect of drugs. Presence of various end users such as pharmaceuticals, clinical research organizations (CROs), and healthcare providers has increased the demand for e-clinical solution software. The global e-clinical solution software market was valued at US$ 3,005 Mn in 2014 and is expected to expand at a CAGR of 13.8% from 2014 to 2020 to reach US$ 6,515.3 Mn by 2020.
View Sample Report @ http://www.persistencemarketresearch.com/samples/2884
In North America, the average cost of research and development for a successful pharmaceutical drug continues to increase from pre-clinical stage i.e. initial development stage of drug till FDA approval i.e. launch of the drug in the market. According to Oracle Corporation – an e-clinical software company – the share of global clinical trials conducted in North America has reduced from 30% in 2006 to 19% in 2010. This was due to complex regulatory and legal frameworks in North America, which led to shifting of the clinical trials market to developing countries such as India and China. This may lead to sluggish growth of clinical trials in the region.
Countries in Central and Eastern Europe provide abundant opportunities to life science companies for clinical development. According to Oracle Corporation – the percentage of clinical trials conducted in Western Europe has decreased from 25% to 19% and in Eastern Europe; the percentage has increased from 10% to 13% during 2006-2010.
To Know About Latest Report Click Here: http://www.persistencemarketresearch.com/market-research/e-clinical-solution-market.asp
Persistence Market Research (PMR) is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. PMR boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs.
PMR stands committed to bringing more accuracy and speed to clients’ business decisions. From ready-to-purchase market research reports to customized research solutions, PMR’s engagement models are highly flexible without compromising on its deep-seated research values.
Persistence Market Research Pvt. Ltd
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353